Navamedic ASA: Trading Update
Oslo, 23 December 2021 – Navamedic ASA (OSE: NAVA) today announces a trading update based on updated revenue growth expectation for the full-year 2021 of around 30%, compared to the previously communicated annual growth target of 20%. The revenue growth is driven by strong performance in Q4 with a particularly strong December month.Reference is made to Navamedic’s communicated target of 20% annual growth for 2021. As the company’s preliminary financial results for Q4, and hence the full year 2021, represent a noticeable improvement compared to the communicated target for 2021, the company